Evidence map›Paper›PMID 22247000›Full record

ArticleEMBO molecular medicine2012

Mutant p63 causes defective expansion of ectodermal progenitor cells and impaired FGF signalling in AEC syndrome.

Giustina Ferone, Helen A Thomason, Dario Antonini, Laura De Rosa, Bing Hu, Marica Gemei, Huiqing Zhou, Raffaele Ambrosio, David P Rice, Dario Acampora and 8 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 83 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Master regulatory role of p63 in epidermal development and disease.Cellular and molecular life sciences : CMLS · 2018
    Review
  19. Protein aggregation of the p63 transcription factor underlies severe skin fragility in AEC syndrome.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 6 countries.

Giustina FeroneFondazione IRCCS SDN, Napoli, Italy.
Helen A Thomason
Dario Antonini
Laura De Rosa
Bing Hu
Marica Gemei
Huiqing Zhou
Raffaele Ambrosio
David P Rice
Dario Acampora
Hans van Bokhoven
Luigi Del Vecchio
Maranke I Koster
Gianluca Tadini
Bradley Spencer-Dene
Michael Dixon
Jill Dixon
Caterina Missero
Ceinge Biotecnologie Avanzate (Italy) · ITRadboud University Medical Center · NLSDN Istituto di Ricerca Diagnostica e Nucleare · ITUniversity of Manchester · GBCancer Research UK · GBHelsinki University Hospital · FIInstitute of Genetics and Biophysics · ITManchester Academic Health Science Centre · GBUniversity of Colorado Anschutz Medical Campus · USUniversity of Lausanne · CHUniversity of Milan · ITUniversity of Modena and Reggio Emilia · IT

Funding

The role of p63 in normal epidermal differentiation and ectodermal dysplasiasR00AR054696 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI KOSTER, MARANKE I. · 2009 to 2011
$747k
The role of p63 in normal epidermal differentiation and ectodermal dysplasiasK99AR054696 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI KOSTER, MARANKE I. · 2007 to 2008
$180k
Medical Research Council G0901539NIAMS NIH HHS AR054696NIAMS NIH HHS K99 AR054696NIAMS NIH HHS R00 AR054696Telethon GGP09230
6 · The paper itself

Abstract

Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome, which is characterized by cleft palate and severe defects of the skin, is an autosomal dominant disorder caused by mutations in the gene encoding transcription factor p63. Here, we report the generation of a knock-in mouse model for AEC syndrome (p63(+/L514F) ) that recapitulates the human disorder. The AEC mutation exerts a selective dominant-negative function on wild-type p63 by affecting progenitor cell expansion during ectodermal development leading to a defective epidermal stem cell compartment. These phenotypes are associated with impairment of fibroblast growth factor (FGF) signalling resulting from reduced expression of Fgfr2 and Fgfr3, direct p63 target genes. In parallel, a defective stem cell compartment is observed in humans affected by AEC syndrome and in Fgfr2b(-/-) mice. Restoring Fgfr2b expression in p63(+/L514F) epithelial cells by treatment with FGF7 reactivates downstream mitogen-activated protein kinase signalling and cell proliferation. These findings establish a functional link between FGF signalling and p63 in the expansion of epithelial progenitor cells and provide mechanistic insights into the pathogenesis of AEC syndrome.

Indexed as

Cell ProliferationSignal TransductionAnimalsCleft LipCleft PalateEctodermEctodermal DysplasiaEye AbnormalitiesEyelidsFemaleFibroblast Growth FactorsHumansMaleMiceMice, Inbred C57BLMice, KnockoutFibroblast Growth FactorsTP63 protein, humanTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID22247000
PMCPMC3376849
OpenAlexW1812133033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.